Our data also suggests that 5-FU chemotherapy is potentially an effective approach to overcome human colorectal cancer nonresponse to PD-1 blockade immunotherapy by suppressing MDSCs to reverse PD-L1-independent immune suppression mechanism. This evidence concerns the gene CD274 and colorectal cancer.